Table 3.
Demographics.
| Patients (n = 38) | |
|---|---|
| Median age, years (IQR) | 71.5 (65–79) |
| Male sex, n (%) | 18 (47%) |
| Medical history or risk factors, n (%) | |
| arterial hypertension | 23 (61%) |
| hypercholesterolemia | 23 (61%) |
| diabetes mellitus | 9 (24%) |
| obesity | 12 (32%) |
| former or current smoker † | 15 (41%) |
| atrial fibrillation | 4 (11%) |
| ICH | 4 (11%) |
| Use of antithrombotic therapy at presentation, n (%)§ | |
| no antithrombotic therapy | 22 (58%) |
| antiplatelet therapy | 9 (24%) |
| anticoagulant therapy | 8 (21%) |
| Median NIHSS at presentation (IQR) ‡ | 7 (1–14) |
| Median interval presentation – MR imaging, days (IQR) ¶ | 16 (4–60) |
| Median interval presentation – PET imaging, days (IQR) | 81 (36–114) |
| Median interval MR imaging – PET imaging, days (IQR) ¶ | 56 (29–108) |
IQR = interquartile range; NIHSS = National Institutes of Health Stroke Scale.
† 1 missing data point. ‡ 2 missing data points. § The sum of the percentages is > 100 % as 1 patient used both antiplatelet and anticoagulant therapy and is counted twice. ¶ n = 35 (3 patients did not undergo MRI).